Pamabrom

Drug profile

Key facts

Pamabrom is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including Adora1.

• Molecular targets: Adora1 (1 listed in DrugCentral).
• Molecular formula: C7H7BrN4O2; molecular weight 259.06 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Contraindications (15)

• Alcoholism
• Angle-closure glaucoma
• Benign prostatic hyperplasia
• Bladder outflow obstruction
• Blood coagulation disorder
• Chronic idiopathic constipation
• Disease of liver
• Hepatic failure
• Hypertensive disorder
• Hyperthyroidism
• Ocular hypertension
• Peptic ulcer
• Poisoning by acetaminophen
• Retention of urine
• Vitamin K Deficiency Induced Hypoprothrombinemia

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Adenosine receptor A1	Adora1	unknown	Ki 4.99

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
—	FDA	—	—

Chemical structure

• Molecular formula: C₇H₇BrN₄O₂
• Molecular weight: 259.06 g/mol
• CAS number: 10381-75-6
• InChIKey: SKTFQHRVFFOHTQ-UHFFFAOYSA-N
• PubChem CID: 11806

CN1C2=C(N=C(Br)N2)C(=O)N(C)C1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Pamabrom work?

Its molecular targets in DrugCentral include Adora1.

What is the chemical formula of Pamabrom?

Pamabrom has the molecular formula C7H7BrN4O2 and a molecular weight of 259.06 g/mol.

Sources

• DrugCentral drug card 2047 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2104825 — compound record and bioactivity
• PubChem CID 11806 — chemical identifiers
• DrugBank DB14018 — drug record
• FDA UNII UA8U0KJM72 — substance identity
• DailyMed: FDA labels for Pamabrom — current prescribing information (label search)

How this page is built: methodology · editorial policy & corrections.